Vincent Kipkorir

Dr. Vincent Kipkorir

Department of Human Anatomy and Physiology, College of Health Sciences, University of Nairobi, Nairobi, Nairobi City, Kenya
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in Annals of Vascular Surgery
Verified
Journal Article
Closed access
ICIsaac Cheruiyot
Isaac Cheruiyot
Vincent KipkorirVincent Kipkorir
Vincent Kipkorir
BNBrian Ngure
Brian Ngure
MMMusa Misiani
Musa Misiani
JMJeremiah Munguti
Jeremiah Munguti
JOJulius Ogeng'O
Julius Ogeng'O

7 September 2020
Verified
Journal Article
Open access
PDF file
Brandon Michael HenryBrandon Michael Henry
Brandon Michael Henry
ICIsaac Cheruiyot
Isaac Cheruiyot
JVJens Vikse
Jens Vikse
VMVictor Mutua
Victor Mutua
Vincent KipkorirVincent Kipkorir
Vincent Kipkorir
Giuseppe LippiGiuseppe Lippi
Giuseppe Lippi
There is a compelling need to identify clinical and laboratory predictors of unfavorable clinical course and death in patients with coronavirus disease (COVID-19). A trend towards low lymphocyte count and high neutrophil counts in patients with poor outcomes has been reported by earlier studies. We aim to synthesize existing data evaluating the relationship between clinical outcomes and abnormal neutrophil and lymphocyte counts at admission in COVID-19 patients. An electronic search was carried out in PubMed, China National Knowledge Infrastructure (CNKI) and Cochrane Central Register of Controlled Trials (CENTRAL) to identify eligible studies reporting frequency data on neutrophilia and lymphopenia at admission in hospitalization in COVID-19 patients. Pooled odds ratios of clinical outcomes for each parameter were calculated using Comprehensive Meta-Analysis. A total of 22 studies (4,969 patients) were included in this meta-analysis. Lymphopenia at admission was found to be significantly associated with increased odd of progression to severe disease (odds ratio [OR], 4.20; 95% confidence interval [95CI%], 3.46-5.09) and death (OR, 3.71; 95%CI, 1.63-8.44). Neutrophilia at admission was also found to be significantly associated with increased odd of progression to severe disease (OR, 7.99; 95%CI, 1.77-36.14) and death (OR, 7.87; 95%CI, 1.75-35.35). Subgroup analysis revealed that COVID-19 patients with severe lymphopenia (<0.5 x10×9/L) had 12-fold increased odds of in-hospital mortality. Admission lymphopenia and neutrophilia are associated with poor outcomes in patients with COVID-19. Regular monitoring and early and even more aggressive intervention shall hence be advisable in patients with low lymphocyte and high neutrophil counts. These variables may be useful in risk stratification models.


15 May 2024 in Annals of Medicine & Surgery
Verified
Journal Article
Open access
MCMatei-Alexandru Cozma
Matei-Alexandru Cozma
Mihnea-Alexandru GamanMihnea-Alexandru Gaman
Mihnea-Alexandru Gaman
BSBahadar S Srichawla
Bahadar S Srichawla
ADArkadeep Dhali
Arkadeep Dhali
MMMuhammad Romail Manan
Muhammad Romail Manan
Camelia DiaconuCamelia Diaconu
Camelia Diaconu
Acute cholangitis is a potentially life-threatening bacterial infection of the intra and/or extrahepatic bile ducts. It remains the second and third cause of community-acquired and hospital-acquired bacteremia, respectively, and is associated with mortality rates of up to 15%, despite advances in broad-spectrum antimicrobial therapy and improved access to emergency biliary tract decompression procedures. Even though not much has changed in recent years in terms of diagnosis or treatment, new data have emerged regarding multidrug-resistant bacteria that serve as etiologic agents of cholangitis. Moreover, different approaches in antibiotic regimes depending on severity grading and bile sample cultures as well as novel minimally invasive endoscopic procedures that can help when consecrated treatments such as endoscopic retrograde cholangiopancreatography (ERCP) fail, cannot be performed, or are unavailable have been proposed. This state-of-the-art review aims to offer a complete and updated assessment of the epidemiology, novel diagnostic and therapeutic methods, complications, and prognostic variables of acute cholangitis. The authors will review the prognostic implications of unusual complications, the relevance of regular bile samples and antibiograms, and their new role in guiding antibiotic therapy and limiting antibiotic resistance to present an organized and comprehensive approach to the care of acute cholangitis.

1 January 2024 in Sage Open Medicine
Verified
Journal Article
Open access
BSBahadar S Srichawla
Bahadar S Srichawla
MMMuhammad Romail Manan
Muhammad Romail Manan
Vincent KipkorirVincent Kipkorir
Vincent Kipkorir
ADArkadeep Dhali
Arkadeep Dhali
SDSebastian Diebel
Sebastian Diebel
MGMihnea-Alexandru Găman
Mihnea-Alexandru Găman
Background: Arboviruses are RNA viruses and some have the potential to cause neuroinvasive disease and are a growing threat to global health. Objectives: Our objective is to identify and map all aspects of arbovirus neuroinvasive disease, clarify key concepts, and identify gaps within our knowledge with appropriate future directions related to the improvement of global health. Methods: Sources of Evidence: A scoping review of the literature was conducted using PubMed, Scopus, ScienceDirect, and Hinari. Eligibility Criteria: Original data including epidemiology, risk factors, neurological manifestations, neuro-diagnostics, management, and preventive measures related to neuroinvasive arbovirus infections was obtained. Sources of evidence not reporting on original data, non-English, and not in peer-reviewed journals were removed. Charting Methods: An initial pilot sample of 30 abstracts were reviewed by all authors and a Cohen’s kappa of κ = 0.81 (near-perfect agreement) was obtained. Records were manually reviewed by two authors using the Rayyan QCRI software. Results: A total of 171 records were included. A wide array of neurological manifestations can occur most frequently, including parkinsonism, encephalitis/encephalopathy, meningitis, flaccid myelitis, and Guillain-Barré syndrome. Magnetic resonance imaging of the brain often reveals subcortical lesions, sometimes with diffusion restriction consistent with acute ischemia. Vertical transmission of arbovirus is most often secondary to the Zika virus. Neurological manifestations of congenital Zika syndrome, include microcephaly, failure to thrive, intellectual disability, and seizures. Cerebrospinal fluid analysis often shows lymphocytic pleocytosis, elevated albumin, and protein consistent with blood-brain barrier dysfunction. Conclusions: Arbovirus infection with neurological manifestations leads to increased morbidity and mortality. Risk factors for disease include living and traveling in an arbovirus endemic zone, age, pregnancy, and immunosuppressed status. The management of neuroinvasive arbovirus disease is largely supportive and focuses on specific neurological complications. There is a need for therapeutics and currently, management is based on disease prevention and limiting zoonosis.

13 October 2022 in Tropical Medicine & International Health
Verified
Journal Article
Closed access
Vincent KipkorirVincent Kipkorir
Vincent Kipkorir
ADArkadeep Dhali
Arkadeep Dhali
BSBahadar S Srichawla
Bahadar S Srichawla
LKL V Simhachalam Kutikuppala
L V Simhachalam Kutikuppala
MCMadeleine Cox
Madeleine Cox
MGMihnea Alexandru Găman
Mihnea Alexandru Găman